Portugal, March 23 -- Portugal based NOVARTIS FARMACEUTICA has secured contract from Servico De Saude Da Regiao Autonoma Da Madeira, Epe-Ram for Tyrosinakinase Inhibitors - Dabrafenib. The value of the contract is worth 2259236 EUR.
Published by HT Digital Content Services with permission from Pivotal Sources....